These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26628583)

  • 21. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cavalier E; Chanson P
    Endocrine; 2016 Aug; 53(2):543-50. PubMed ID: 27106800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D and primary hyperparathyroidism (PHPT).
    Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people.
    Sayed-Hassan R; Abazid N; Alourfi Z
    Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum PTH reference values in an adult Brazilian population: implications for the diagnosis of hyperparathyroidism.
    Rosario PW; Calsolari MR
    Arch Endocrinol Metab; 2019; 63(2):182-185. PubMed ID: 30916167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism.
    Adler JT; Sippel RS; Chen H
    Ann Surg Oncol; 2010 Nov; 17(11):2958-62. PubMed ID: 20544293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.
    Walker MD; Cong E; Kepley A; Di Tullio MR; Rundek T; Homma S; Lee JA; Liu R; Young P; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2014 Feb; 99(2):671-80. PubMed ID: 24285686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism.
    Walker MD; Nishiyama KK; Zhou B; Cong E; Wang J; Lee JA; Kepley A; Zhang C; Guo XE; Silverberg SJ
    J Clin Endocrinol Metab; 2016 Mar; 101(3):905-13. PubMed ID: 26745256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
    Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
    Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining vitamin D status by secondary hyperparathyroidism in the U.S. population.
    Ginde AA; Wolfe P; Camargo CA; Schwartz RS
    J Endocrinol Invest; 2012 Jan; 35(1):42-8. PubMed ID: 21606669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H; Khan AH; Riaz M; Karimi H; Talati J
    Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seasonal changes in serum calcium, PTH and vitamin D levels in patients with primary hyperparathyroidism.
    Nevo-Shor A; Kogan S; Joshua BZ; Bahat-Dinur A; Novack V; Fraenkel M
    Bone; 2016 Aug; 89():59-63. PubMed ID: 27260647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis.
    West NE; Lechtzin N; Merlo CA; Turowski JB; Davis ME; Ramsay MZ; Watts SL; Stenner SP; Boyle MP
    Chest; 2011 Aug; 140(2):469-474. PubMed ID: 21393390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism.
    Belli M; Martin RM; Brescia MDG; Nascimento CP; Massoni Neto LM; Arap SS; Ferraz-de-Souza B; Moyses RMA; Peacock M; Montenegro FLM
    PLoS One; 2020; 15(12):e0244162. PubMed ID: 33382714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and laboratory profile of primary hyperparathyroidism in India.
    Priya G; Jyotsna VP; Gupta N; Chumber S; Bal CS; Karak AK; Seth A; Ammini AC
    Postgrad Med J; 2008 Jan; 84(987):34-9. PubMed ID: 18230749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of plasma PTH and their implication for defining a reference interval.
    Rejnmark L; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):37-43. PubMed ID: 21039730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects.
    Carnevale V; Nieddu L; Romagnoli E; Battista C; Mascia ML; Chiodini I; Eller-Vainicher C; Frusciante V; Santini SA; La Porta M; Minisola S; Scillitani A
    Bone; 2010 Sep; 47(3):626-30. PubMed ID: 20601288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism.
    Basińska-Lewandowska M; Lewiński A; Lewandowski KC; Skowrońska-Jóźwiak E
    Front Endocrinol (Lausanne); 2022; 13():1013362. PubMed ID: 36187131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.
    Boudville N; Inderjeeth C; Elder GJ; Glendenning P
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):299-304. PubMed ID: 20507339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.